Burna AI · 6 days ago
Strategic Advisor – AI in Oncology
Burna AI is a healthcare technology startup revolutionizing oncology workflows through AI-powered adverse event automation. They are seeking Strategic Advisors with deep experience in oncology, artificial intelligence, and healthcare innovation to guide long-term clinical and technical strategy.
Health CareHealth DiagnosticsSaaSSoftware
Responsibilities
Advise on the strategic application of AI and machine learning to oncology workflows, adverse-event automation, and clinical documentation
Provide guidance on clinical validation, safety considerations, and real-world adoption of AI-enabled tools within oncology settings
Ensure AI solutions align with real clinical practice, minimizing burden while maintaining accuracy, compliance, and clinician trust
Support decisions related to scaling AI systems across cancer centers and health systems, including integration with EHR environments
Contribute to strategic discussions, publications, or panels focused on AI in oncology and clinical automation
Where appropriate, facilitate introductions to oncology leaders, digital health innovators, academic partners, or investors
Qualification
Required
Senior clinician, physician-executive, or healthcare leader with oncology domain expertise
Demonstrated experience with AI, machine learning, digital health, or advanced analytics in healthcare
Familiarity with clinical workflows, EHR environments, and enterprise adoption challenges
Strategic mindset with comfort operating at a board level
Interest in shaping responsible, clinically grounded AI innovation
Preferred
Prior advisory board, innovation committee, or leadership experience preferred
Benefits
Equity participation aligned with advisory contribution
Opportunity to participate in Burna AI’s seed financing round
Direct impact on scaling AI-enabled oncology infrastructure
Collaboration with senior clinicians, AI leaders, and healthcare innovators
Company
Burna AI
Burna AI is the world’s first AI CTCAE copilot that automates adverse event detection and grading for oncology clinics and trials.
Funding
Current Stage
Early StageCompany data provided by crunchbase